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and growth. For example, nutrition can also influence of stem cells in the adult heart and their capacity for
functional repair after injury.growth indirectly by affecting behavior: abnormally high
levels of amino acids in the fat body can negatively feed
back on larval feeding and reduce growth (Zinke et al., While newts and zebrafish can regenerate their hearts,
1999). The data discussed here show that low levels of humans (and most mammals) cannot. For this reason,
fat body amino acids also reduce growth. Future re- myocardial infarctions produce permanent loss of car-
search will no doubt determine whether it is intermediate diac muscle mass and function. One clear-cut remedy
amino acid levels that are needed to promote larval to this problem would be to stimulate the heart to make
growth without inhibiting larval feeding. For the moment new cells by inducing the existing cardiac cells to divide.
though, this paper takes us much closer to a molecular There is one mouse strain (MRL) that appears to be able
understanding the humoral control of growth in flies. It to carry out some cardiac regeneration in response to
establishes the fat body as an amino acid sensor, which injury, and much research is aimed at the genes respon-
uses TOR signaling to generate a humoral signal that sible for this ability (Leferovich et al., 2001). Thus far, it
influences insulin signaling and growth in other tissues. appears that at least six genes contribute to this
multigenic trait. There have been reports of dividing car-
diac myocytes in the adult hearts of a number of mam-Gemma L. Bradley1 and Sally J. Leevers2
mals, but their number and physiological relevance are1BioMed Central, Middlesex House
still debated. However, despite the existence of dividing34-42 Cleveland Street
myocytes, attempts to induce such proliferation geneti-London W1T 4LB
cally, pharmacologically, or surgically have been met2 Growth Regulation Laboratory
with largely disappointing results. None of these stimuliCancer Research UK London Research Institute
has activated myocyte proliferation that is substantiveP.O. Box 123
enough to make a functional difference. A second poten-44 Lincoln’s Inn Fields
tial remedy for myocardial cell loss would be to stimulateLondon WC2A 3PX
stem cells to participate in the formation of new cardiacUnited Kingdom
muscle tissue. The pluripotency of embryonic stem (ES)
cells is no longer a point of debate, but the restrictedSelected Reading
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and differentiate into host cell types (e.g., Krause et al.,
Davis, K.T., and Shearn, A. (1977). Science 196, 438–440. 2001) have generated strong interest in the potential
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surrounds these findings, and also the issue of whether
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be affected. Experimental animal studies have provided
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In several studies, cells were isolated from bone marrow(1999). Development 126, 5275–5284.
based on cell surface antigen expression (Lin, cKit)
and injected into the hearts of mice that had been sub-
jected to a myocardial infarction (Jackson et al., 2001;
Orlic et al., 2001a). These cells formed new cardiac tis-
sue and functional improvement ensued. Given the inva-
sive nature of cardiac injection, other groups subse-Hope for a Broken Heart?
quently showed that bone marrow-derived cells could
home to an injured heart and that this process could be
stimulated by growth factor treatment (stem cell factor
and granulocyte-colony stimulating factor) (Orlic et al.,Heated debate has surrounded the issue of whether
adult stem cells can differentiate into cardiac myo- 2001b).
Are any of these observations relevant to humans?cytes and contribute to the function of the heart. In
this issue of Cell, Beltrami et al. (2003) demonstrate The approach used to investigate this question was to
examine hearts transplanted from human females intostem cells in the adult rat heart that differentiate into
cardiac myocytes in vitro and, when injected into the males for cardiac myocytes with a Y chromosome. The
reasoning was that any such cell would have to be de-adult rat heart, can reconstitute the injured myocar-
dium and improve function. These findings should rived from a circulating stem cell or from a transdifferen-
tiation event from a circulating cell of the transplantweigh heavily in future debates about the existence
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recipient. Four studies were published which were het- these questions will certainly make for some interesting
erogeneous in their findings (Glaser et al., 2002; biology and perhaps future therapies.
Laflamme et al., 2002; Muller et al., 2002; Quaini et al.,
2002). Two studies found ample evidence of Y chromo- Leslie A. Leinwand
some-bearing cardiac myocytes in the transplanted Department of Molecular, Cellular,
hearts. A second study found this to be a very rare and Developmental Biology
finding and questioned its significance. A third report University of Colorado
found no evidence of Y chromosome-bearing cardiac Boulder, Colorado 80309
myocytes. Multiple editorials then appeared, with much
finger pointing about these discrepancies and the vari- Selected Reading
ous parties each claiming that their own techniques
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chi-were superior. The source of this exceptional furor ap-
menti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., et al.pears to lie in the potential for medical therapy that
(2003). Cell 114, this issue, 763–776.these studies hold. The source of the cells from the
Glaser, R., Lu, M.M., Narula, N., and Epstein, J.A. (2002). Circulationvarious recipients remains unknown.
106, 17–19.In addition to circulating stem cells, there has been
Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J.,considerable interest in the existence of resident stem
Majesky, M.W., Entman, M.L., Michael, L.H., Hirschi, K.K., andcells in tissues other than the bone marrow. The article
Goodell, M.A. (2001). J. Clin. Invest. 107, 1395–1402.
by Beltrami et al. in this issue of Cell provides convincing
Krause, D.S., Theise, N.D., Collector, M.I., Henegariu, O., Hwang, S.,
evidence that there is a stem cell population that resides Gardner, R., Neutzel, S., and Sharkis, S.J. (2001). Cell 105, 369–377.
in the adult heart. The stem cells can be isolated and
Laflamme, M.A., Myerson, D., Saffitz, J.E., and Murry, C.E. (2002).
expanded in culture indefinitely. The cells were identified Circ. Res. 90, 634–640.
and then isolated from the hearts of older adult rats Leferovich, J.M., Bedelbaeva, K., Samulewicz, S., Zhang, X.M.,
(20–23 months of age). They are characterized based Zwas, D., Lankford, E.B., and Heber-Katz, E. (2001). Proc. Natl.
on the following pattern of cell surface markers: Lin, Acad. Sci. USA 98, 9830–9835.
c-Kit, CD45, CD34. These cells were able to differ- Muller, P., Pfeiffer, P., Koglin, J., Schafers, H.J., Seeland, U., Janzen,
entiate into cardiac myocytes, smooth muscle cells, and I., Urbschat, S., and Bohm, M. (2002). Circulation 106, 31–35.
endothelial cells in culture. However, in culture, the “dif- Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker,
R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T.,ferentiated” cells had an immature phenotype. To test
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likely because untreated animals did not survive with
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structures. One potential caveat for these findings would
be if the stem cells had fused with existing host cells—
this might appear to be differentiation when, in fact, it
would be hybrid cells giving the appearance of differenti-
ation. However, the Beltrami et al. study ruled this out Apoptosis: A Process
by a number of criteria, including showing that the num-
with a ()NAC for Complexityber of new myocytes is orders of magnitude higher than
the injected cells and stating that the DNA content of
the new cells is diploid and not tetraploid. The cells
purified from the adult rat heart satisfy all of the proper-
Most programmed cell deaths in the nematode C. ele-ties of cardiac stem cells. They are clonogenic, self-
gans require ced-3 caspase activity. In a recent paper,renewing, and able to give rise to at least three different
Bloss et al. (2003) reveal a new C. elegans death inhibi-cell types. Finally, they participate in the formation of
tor, icd-1, whose loss can promote apoptosis indepen-new, functional myocardium.
dently of ced-3.Despite the convincing nature of this study, there are
numerous interesting questions to be pursued. Multipo-
Apoptosis (or programmed cell death), a ubiquitoustent adult progenitor cells, or MAPCs, which have also
metazoan cell death process, is crucial for proper organ-been shown to have cardiogenic potential, are charac-
ismal development, maintenance of cell number homeo-terized as being negative for the marker (c-Kit) used to
stasis, and elimination of diseased or otherwise harmfuldefine the cells in the Beltrami et al. study. In addition,
cells. In many instances, organismal life is impossiblethe fact that the adult stem cells in this study can form
in the absence of the machinery for cell death. Geneticendothelium, smooth muscle, and cardiac muscle is
studies in model organisms have proven a fertile groundconfounding, since these three cell types arise from
for the discovery and subsequent study of genes thatthree different cell lineages. Finally, if these cells exist
regulate apoptosis. Pioneering work by Horvitz and col-and lie dormant in the heart, why do they not mobilize
and divide in response to an injury? The answers to leagues in the 1980s identified three genes essential for
